Hepatitis-B-Immunglobulin Behring Soluzione iniettabile

Country: Switzerland

Language: Italian

Source: Swissmedic (Swiss Agency for Therapeutic Products)

Active ingredient:

immunoglobulinum humanum hepatitidis B

Available from:

CSL Behring AG

ATC code:

J06BB04

INN (International Name):

immunoglobulinum humanum hepatitidis B

Pharmaceutical form:

Soluzione iniettabile

Composition:

immunoglobulinum humanum hepatitidis B min. 200 U.I. corresp. immunoglobulinum humanum normale min. 95 % corresp. proteina 100-170 mg, glycinum, natrii chloridum, aqua q.s. ad solutionem pro 1 ml.

Class:

B

Therapeutic group:

Emoderivati

Therapeutic area:

Immunizzazione passiva contro l'Epatite B, a partire dalla Nascita

Authorization status:

zugelassen

Authorization date:

2004-03-01